Lv5
1260 积分 2023-08-04 加入
Molecular classification of hormone receptor-positive HER2-negative breast cancer
1个月前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
1个月前
已完结
Gastric Cancer
1个月前
已完结
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety
2个月前
已完结
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors
2个月前
已完结
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
3个月前
已完结
Randomized, Phase III Trial of Mixed Formulation of Fosrolapitant and Palonosetron (HR20013) in Preventing Cisplatin-Based Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: PROFIT
3个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
4个月前
已完结
Treatment of NSCLC after chemoimmunotherapy - are we making headway?
9个月前
已完结
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
9个月前
已完结
皖公网安备34019202002308
